| Not Yet Recruiting | A Study of E6742 in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2026-03-31 |
| Recruiting | A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fi Biliary Tract Cancer | — | 2025-07-10 |
| Recruiting | A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Gen Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures | — | 2024-11-18 |
| Recruiting | A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab Alzheimer's Disease | — | 2024-02-14 |
| Completed | A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders Psychotic Disorders | — | 2023-03-30 |
| Completed | A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder Sleep Initiation and Maintenance Disorders | Phase 2 | 2022-11-30 |
| Completed | A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants Healthy Volunteers | Phase 1 | 2022-07-01 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Part Lupus Erythematosus, Systemic | Phase 1 / Phase 2 | 2022-04-14 |
| Completed | A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout Gout | Phase 3 | 2021-12-21 |
| Active Not Recruiting | A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhance Lymphoma, Follicular | — | 2021-08-16 |
| Completed | A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants Healthy Volunteers | Phase 1 | 2020-12-28 |
| Completed | A Study of Lemborexant in Chinese Participants With Insomnia Disorder Sleep Initiation and Maintenance Disorders | Phase 3 | 2020-11-06 |
| Completed | A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2020-10-28 |
| Completed | A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants Healthy Volunteer | Phase 1 | 2020-10-26 |
| Completed | A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia. Sleep Initiation and Maintenance Disorders | — | 2020-10-17 |
| Completed | A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabe Healthy Participants | Phase 1 | 2020-10-16 |
| Completed | A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Incl Parkinson Disease | — | 2020-10-14 |
| Active Not Recruiting | A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Breast Neoplasms | Phase 1 | 2020-10-09 |
| Completed | Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Recept Breast Neoplasms | Phase 1 | 2020-09-30 |
| Recruiting | Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite Hepatic Impairment | Phase 1 | 2020-02-27 |
| Completed | A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast G Cholangiocarcinoma | Phase 2 | 2020-01-22 |
| Active Not Recruiting | A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor Solid Neoplasms | Phase 1 / Phase 2 | 2019-09-05 |
| Completed | A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma Carcinoma, Hepatocellular, Carcinoma, Neoplasms, Glandular and Epithelial | — | 2019-05-14 |
| Completed | A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immedi Healthy Subjects | Phase 1 | 2019-04-13 |
| Active Not Recruiting | A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) Solid Neoplasms, Colorectal Neoplasms, Gastrointestinal Tumors | Phase 1 | 2019-03-05 |
| Completed | A Study of Intravenous Perampanel in Japanese Participants With Epilepsy Epilepsy, Seizures | Phase 2 | 2018-11-27 |
| Completed | Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor Solid Tumor | Phase 1 | 2018-08-06 |
| Completed | Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | Phase 2 | 2018-04-09 |
| Completed | Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects Healthy Subjects | Phase 1 | 2018-03-20 |
| Completed | A Study of E7130 in Participants With Solid Tumors Solid Tumors | Phase 1 | 2018-02-05 |
| Completed | A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma Carcinoma, Hepatocellular | Phase 1 | 2018-01-16 |
| Terminated | Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects Healthy Participants | Phase 1 | 2017-12-21 |
| Completed | Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Hea Healthy Participants | Phase 1 | 2017-12-18 |
| Completed | Clinical Trial of Ultra-high Dose Methylcobalamin for ALS Amyotrophic Lateral Sclerosis | Phase 3 | 2017-11-01 |
| Active Not Recruiting | Study of E7389 Liposomal Formulation in Participants With Solid Tumor Solid Tumor | Phase 1 | 2017-08-18 |
| Completed | Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partia Partial Onset Seizures | Phase 3 | 2017-06-28 |
| Completed | Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects Healthy Participants | Phase 1 | 2017-02-14 |
| Completed | A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 | 2017-02-13 |
| Completed | Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors Solid Tumors | Phase 1 | 2017-01-12 |
| Completed | A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China Differentiated Thyroid Cancer (DTC) | Phase 3 | 2017-01-11 |
| Completed | A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2017-01-10 |
| Completed | A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics Rheumatoid Arthritis | Phase 2 | 2016-11-26 |
| Completed | A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexa Rheumatoid Arthritis | Phase 2 | 2016-10-20 |
| Terminated | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzhei Alzheimer's Disease | Phase 3 | 2016-10-20 |
| Completed | Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subject Healthy Subjects | Phase 1 | 2016-10-01 |
| Completed | Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC) Unresectable Hepatocellular Carcinoma (HCC) | Phase 1 | 2016-09-01 |
| Completed | Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epileps Partial Seizures (With or Without Secondary Generalized Seizures), Primary Generalized Tonic-clonic Seizures | — | 2016-08-01 |
| Completed | Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence E Partial Seizures (With or Without Secondary Generalized Seizures), Primary Generalized Tonic-clonic Seizures | — | 2016-08-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Ep Epilepsy, Partial-onset Seizures | — | 2016-04-11 |
| Completed | Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphom Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma | Phase 2 | 2016-03-28 |
| Completed | A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas Sarcoma, Soft Tissue | — | 2016-03-01 |
| Completed | Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combinatio Biliary Tract Cancer | Phase 2 | 2015-10-23 |
| Completed | Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Re Carcinoma, Renal Cell | Phase 1 | 2015-07-01 |
| Completed | Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Can Thyroid Neoplasms | — | 2015-05-20 |
| Completed | An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Epilepsy | Phase 3 | 2015-05-12 |
| Completed | Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Ari Dementia With Lewy Body Disease | — | 2015-04-20 |
| Completed | Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Asp Gastric Ulcer, Duodenal Ulcer | — | 2015-03-17 |
| Completed | A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB) Dementia, Lewy Body, Lewy Body Disease | Phase 4 | 2015-03-01 |
| Completed | A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Su Healthy Subjects | Phase 1 | 2014-11-01 |
| Completed | Phase 1 Study of E7090 in Subjects With Solid Tumor Tumors | Phase 1 | 2014-10-28 |
| Completed | Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects Healthy Volunteers | Phase 1 | 2014-10-01 |
| Completed | Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neur Breast Cancer, HER2-negative Breast Cancer | — | 2014-09-03 |
| Completed | A Study of E2022 Tape Formulation (Overlay-integrated E2022 18 mg Tape Formulation) for Different Application Healthy Subjects | Phase 1 | 2014-09-01 |
| Completed | A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects Healthy Subjects | Phase 1 | 2014-07-01 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Sub Thrombocytopenia Associated With Chronic Liver Disease | Phase 2 | 2014-07-01 |
| Completed | A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 1 / Phase 2 | 2014-05-26 |
| Completed | Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma Hepatocellular Carcinoma | — | 2014-03-06 |
| Completed | Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Pati Malignant Glioma | — | 2014-01-10 |
| Completed | A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects Healthy | Phase 1 | 2013-12-01 |
| Completed | Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated HER2-Negative Breast Cancer, Triple Negative Breast Cancer, Breast Cancer | Phase 3 | 2013-09-26 |
| Completed | A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy an Down Syndrome | Phase 2 | 2013-09-12 |
| Completed | A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunog Alzheimer's Disease | Phase 1 | 2013-09-01 |
| Completed | A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects Healthy | Phase 1 | 2013-09-01 |
| Completed | A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Gastroesophageal Reflux Disease | Phase 3 | 2013-09-01 |
| Completed | A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease Dementia Associated With Cerebrovascular Disease | Phase 4 | 2013-08-05 |
| Completed | Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Sy Lennox-Gastaut Syndrome | — | 2013-06-13 |
| Completed | Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medic Alzheimer's Disease | — | 2013-06-01 |
| Completed | Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combin Alzheimer's Desease | — | 2013-06-01 |
| Completed | Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Cervical Dystonia | — | 2013-04-16 |
| Completed | Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Cervical Dystonia | — | 2013-04-02 |
| Completed | Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study) Malignant Glioma | — | 2013-01-10 |
| Completed | A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 Healthy | Phase 1 | 2013-01-01 |
| Completed | A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103) Solid Tumor | Phase 1 | 2012-12-01 |
| Completed | A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy El Healthy Elderly Male | Phase 1 | 2012-12-01 |
| Completed | Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients Insomnia | — | 2012-10-01 |
| Completed | Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom Chronic Obstructive Pulmonary Disease, Asthma | Phase 4 | 2012-10-01 |
| Completed | Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients Insomnia | — | 2012-10-01 |
| Completed | Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | — | 2012-09-12 |
| Completed | A Study of E7080 in Subjects With Advanced Thyroid Cancer Thyroid Cancer | Phase 2 | 2012-09-03 |
| Completed | A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001) Healthy Male Volunteers | Phase 1 | 2012-08-01 |
| Completed | A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arte Hypervascular Tumor and Arteriovenous Malformation | Phase 3 | 2012-08-01 |
| Completed | A Phase 1 Comparative Study of E2022 Current and New Patch Formulations Healthy | Phase 1 | 2012-08-01 |
| Completed | Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Cont COPD | Phase 4 | 2012-08-01 |
| Completed | A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administe Partial-onset Seizures | Phase 3 | 2012-05-15 |
| Completed | Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydr Alzheimer's Type Dementia | Phase 3 | 2012-03-01 |
| Completed | Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E381 Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin | Phase 2 / Phase 3 | 2011-12-01 |
| Completed | An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previous Soft Tissue Sarcoma | Phase 2 | 2011-11-01 |
| Completed | A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor Breast Cancer | Phase 1 | 2011-10-01 |
| Completed | A Phase I Study of E7050 in Subjects With Solid Tumors Solid Tumor, Gastric Cancer | Phase 1 | 2011-09-01 |
| Completed | E2022 Patch Formulation Multiple Dose Study Healthy | Phase 1 | 2011-09-01 |
| Completed | Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With In Inoperable or Recurrent Breast Cancer | — | 2011-07-19 |
| Completed | E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma Peripheral T-Cell Lymphoma | Phase 1 | 2011-07-01 |
| Completed | A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy J Healthy Adult | Phase 1 | 2011-07-01 |
| Completed | Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Su Gastroesophageal Reflux Disease | Phase 1 | 2011-07-01 |
| Completed | Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatme Gastric or Duodenal Ulcers Caused by Low-dose Aspirin | Phase 2 / Phase 3 | 2011-07-01 |
| Completed | A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males Healthy Adult | Phase 1 | 2011-03-01 |
| Completed | A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperiso Healthy Volunteers | N/A | 2011-02-01 |
| Completed | A Study of E7080 in Subjects With Solid Tumor Cancer | Phase 1 | 2011-02-01 |
| Completed | A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase Dementia With Lewy Bodies (DLB) | Phase 3 | 2011-02-01 |
| Completed | A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride Wi Acute Musculoskeletal Spasm Due to Low Back Pain | Phase 3 | 2011-02-01 |
| Completed | Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive | — | 2011-01-13 |
| Completed | Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis Refractory Reflux Esophagitis | — | 2011-01-01 |
| Completed | Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness Alzheimer's Disease | — | 2010-12-01 |
| Completed | E2022 Patch Formulation Single Dose Phase I Study Japanese Healthy Male Adult Volunteers | Phase 1 | 2010-11-01 |
| Completed | A Long Term Extension Study of E2080 in Lennox-Gastaut Patients Lennox-Gastaut Syndrome | Phase 3 | 2010-11-01 |
| Completed | A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810) Healthy | Phase 2 | 2010-09-01 |
| Completed | Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clini Alzheimer's Disease | — | 2010-06-10 |
| Completed | Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis W Acute Gastritis, Gastric Ulcer | Phase 4 | 2010-05-01 |
| Completed | Study of E3810 for Healthy Japanese Male (Under Fasting Condition) Healthy | Phase 1 | 2010-04-01 |
| Completed | A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition) Healthy | Phase 1 | 2010-04-01 |
| Completed | Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109) Peripheral Neuropathy | Phase 4 | 2010-04-01 |
| Completed | A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu Wi Functional Dyspepsia | Phase 2 | 2010-04-01 |
| Completed | Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis. End-Stage Renal Disease | Phase 4 | 2010-02-01 |
| Completed | An Study of Efficacy and Safety of Clevudine Chronic Hepatitis B | Phase 3 | 2010-02-01 |
| Completed | A Study of MORAb-003 in Patients With Solid Tumor Neoplasms, Solid Tumor | Phase 1 | 2010-01-01 |
| Completed | A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102) Insomnia | Phase 1 | 2010-01-01 |
| Completed | A Study of MORAb-009 in Patients With Solid Tumor Cancer, Mesothelin-positive | Phase 1 | 2009-11-01 |
| Completed | A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors Solid Tumors | Phase 1 | 2009-10-01 |
| Completed | A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Meth Rheumatoid Arthritis | Phase 3 | 2009-07-31 |
| Completed | Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2009-07-24 |
| Completed | A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti Refractory Partial Seizures | Phase 2 | 2009-06-17 |
| Completed | An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic D Refractory Partial Seizures | Phase 2 | 2009-04-01 |
| Completed | E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) Non-small-cell Lung Cancer | Phase 1 | 2009-02-01 |
| Completed | Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patien Refractory Reflux Esophagitis | Phase 2 / Phase 3 | 2008-10-01 |
| Completed | A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150) Insomnia | Phase 3 | 2008-10-01 |
| Completed | A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126) Primary Insomnia | Phase 2 / Phase 3 | 2008-09-01 |
| Completed | A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) | Phase 2 / Phase 3 | 2008-02-01 |
| Completed | A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies Dementia With Lewy Bodies (DLB) | Phase 2 | 2008-02-01 |
| Completed | Study of E7389 for Advanced or Metastatic Breast Cancer Breast Cancer | Phase 2 | 2008-01-01 |
| Completed | A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Stud Dementia With Lewy Bodies (DLB) | Phase 2 | 2007-11-01 |
| Completed | A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome Acute Coronary Syndrome | Phase 2 | 2007-11-01 |
| Completed | A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease Coronary Artery Disease | Phase 2 | 2007-10-01 |
| Completed | A Study in Patients With Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) | Phase 2 / Phase 3 | 2007-04-01 |
| Completed | Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory P Epilepsy | Phase 2 | 2006-12-01 |
| Completed | Phase I Clinical Study of E7389 Cancer | Phase 1 | 2006-06-01 |
| Completed | A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use o Stomach Ulcer | Phase 4 | 2005-08-01 |
| Completed | Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women Postmenopausal Osteoporosis | Phase 3 | 2005-05-01 |
| Terminated | A Study of E7070 in Patients With Gastric Cancer Gastric Cancer | Phase 1 / Phase 2 | 2005-02-01 |
| Completed | A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux D Non-erosive Gastroesophageal Reflux Disease | Phase 3 | 2004-09-01 |
| Completed | Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth S Cervical Dystonia, Spasmodic Torticollis | Phase 2 | 2004-06-01 |
| Completed | The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia. Dementia With Vitamin B12 Deficiency | Phase 4 | 2003-03-01 |
| Completed | Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy Epilepsy | Phase 2 | 2003-02-14 |